Inflammatory mediators in heart failure
- 1 February 2000
- journal article
- review article
- Published by Elsevier in International Journal of Cardiology
- Vol. 72 (3) , 209-213
- https://doi.org/10.1016/s0167-5273(99)00190-4
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Safety and Efficacy of a Soluble P75 Tumor Necrosis Factor Receptor (Enbrel, Etanercept) in Patients With Advanced Heart FailureCirculation, 1999
- Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1999
- A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving MethotrexateNew England Journal of Medicine, 1999
- Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1998
- Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activationJournal of the American College of Cardiology, 1998
- The role of cytokines in disease progression in heart failureCurrent Opinion in Cardiology, 1997
- Basic mechanisms in heart failure: The cytokine hypothesisJournal of Cardiac Failure, 1996
- Circulating concentrations of proinflammatory cytolcines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathyPublished by Elsevier ,1996
- Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human HeartCirculation, 1996
- Formation of Ion-Permeable Channels by Tumor Necrosis Factor-αScience, 1992